Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Arlington
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Arlington, VA

Studies commonly pay $75 to $4,500 per completed study

2,342 clinical trials are currently recruiting participants within 30 miles of Arlington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,342studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Arlington right now

Top 25 of 2,342 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
MedStar Georgetown University Hospital — Washington D.C., District of Columbia (3.7 mi) · Sponsor: National Cancer Institute (NCI)

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Georgetown University - Lombardi CCC — Washington D.C., District of Columbia (3.7 mi) · Sponsor: Abramson Cancer Center at Penn Medicine

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Gonorrhea, Chlamydia Phase 4 Interventional 760 participants sought
Children's National Medical Center — Washington D.C., District of Columbia (3.7 mi) · Sponsor: Westat

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Niemann-Pick Type C Disease, GM1 Gangliosidosis Phase 3 Interventional 147 participants sought
Lysosomal Rare Disorders Research and Treatment Center — Fairfax, Virginia (11.3 mi) · Sponsor: Azafaros B.V.

Tissue Collection for Studies of Lymph Cancer

Hodgkin Disease, Lymphoma, Non-Hodgkin N/A Observational 1,295 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: National Cancer Institute (NCI)

Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies

Healthy Volunteer N/A Observational 2,000 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: National Institute of Mental Health (NIMH)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Georgetown University Medical Center — Washington D.C., District of Columbia (3.7 mi) · Sponsor: Relay Therapeutics, Inc.

Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System

Obstructive Sleep Apnea (OSA) N/A Interventional 160 participants sought
Uniformed Services University — Bethesda, Maryland (7.1 mi) · Sponsor: Uniformed Services University of the Health Sciences

Childhood-Onset Essential Hypertension Natural History Study

Hypertension, Essential Hypertension N/A Observational 2,300 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: National Human Genome Research Institute (NHGRI)

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

Overactive Bladder (OAB), Urinary Urgency N/A Interventional 596 participants sought
MedStar Health — Washington D.C., District of Columbia (3.7 mi) · Sponsor: Medstar Health Research Institute

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma Phase 1 Interventional 25 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: National Cancer Institute (NCI)

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Malignancy, Hematologic, Neoplasms, Hematologic Phase 1 Interventional 86 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: National Cancer Institute (NCI)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Kaiser Permanente-Capitol Hill Medical Center — Washington D.C., District of Columbia (3.7 mi) · Sponsor: SWOG Cancer Research Network

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Carcinoma, Non-Small-Cell Lung Phase 1, Phase 2 Interventional 450 participants sought
Georgetown University ( Site 0036) — Washington D.C., District of Columbia (3.7 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Retina Group of Washington — Chevy Chase, Maryland (8.7 mi) · Sponsor: Genentech, Inc.

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Fairfax, Virginia (11.3 mi) · Sponsor: AstraZeneca

Acoustic Stimulation During Restricted Sleep After Sleep Deprivation

Sleep Deprivation, Sleep Restriction N/A Interventional 44 participants sought
Walter Reed Army Institute of Research — Silver Spring, Maryland (8.7 mi) · Sponsor: Walter Reed Army Institute of Research (WRAIR)

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma, Lymphoma Phase 2 Interventional 152 participants sought
Georgetown University (Data Collection Only) — Washington D.C., District of Columbia (3.7 mi) · Sponsor: Memorial Sloan Kettering Cancer Center

A Prospective Natural History Study of Lymphatic Anomalies

Lymphatic Diseases, Lymphatic Abnormalities N/A Observational 1,200 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Allergic Reactions Phase 4 Interventional 600 participants sought
Children's National Hospital — Washington D.C., District of Columbia (3.7 mi) · Sponsor: ARS Pharmaceuticals, Inc.

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Idiopathic CD4 Lymphopenia Phase 1 Interventional 20 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (7.1 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ulcerative Colitis Phase 4 Interventional 65 participants sought
Capital Digestive Care - MGG Group - Chevy Chase Clinical Research — Chevy Chase, Maryland (8.7 mi) · Sponsor: Takeda
Actively enrolling

Studies you may be able to join near Arlington

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for severe chronic itching

Enrolling adults aged 18 to 90 who have had chronic itching for six months or longer. Not open to itching caused by atopic dermatitis, psoriasis, chronic kidney disease, notalgia paresthetica or medication, nor to people with an autoimmune condition such as lupus, Crohn's disease, ulcerative colitis or rheumatoid arthritis.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for heart failure

This study is enrolling adults in eligible areas of the United States who have been diagnosed with heart failure. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Arlington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Millennium Clinical Trials

3801 Fairfax Dr #32, Arlington, VA 22203
(703) 527-8100

Emerson Clinical Research Institute

★ 4.7
1718 Connecticut Ave NW, Washington, DC 20009
(202) 239-0777
"10/10 Vengan a Emerson Clinic que Wendy y Eliana son amables y tienen tanta paciencia para atenderlos. La clínica tiene recursos que ayudan y el doct…"
— Luis Mejia, 5★

Clinical Research Forum

2025 M St NW #800, Washington, DC 20036
(202) 367-1176

National Center for Health Research

1001 Connecticut Ave NW #1100, Washington, DC 20036
(202) 223-4000

NIH Clinical Center

★ 4.6
10 Center Dr, Bethesda, MD 20892
(301) 496-4000
"Fantastic staff. Very professional and welcoming."
— Paul, 5★

Velocity Clinical Research

★ 5.0
4910 Massachusetts Ave NW Ste. 315, Washington, DC 20016
(202) 998-3833
"Very great staff and respectful"
— Reginald Simms, 5★

GHUCCTS

4000 Reservoir Rd NW #7, Washington, DC 20057
(202) 687-3149

MedStar Health Research Institute

★ 5.0
100 Irving St NW #5123, Washington, DC 20010
(202) 798-8539
"Excellent and caring nurses and staff!+"
— Afoma O, 5★

MD Medical Research

★ 4.9
6357 Oxon Hill Rd Fl 2, Oxon Hill, MD 20745
(301) 329-2612
"Maluu is so kind and professional ❤️"
— Tiffany West, 5★

Clinical trials in Arlington: what's recruiting

The Arlington area currently has 2,342 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Arlington, the most active research areas are:

  • Cancer & Oncology12 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Arlington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Arlington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Arlington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Arlington?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Arlington?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Arlington?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Arlington.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Arlington typically complete one or two studies per year.

Paid clinical trials near Arlington

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of VA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts